BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production
Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology Corp.
Read moreCanada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology Corp.
Read moreInterVivo Solutions Issued Institutional Cannabis Research License by Health Canada Toronto, Ontario–(Newsfile Corp. – February 4, 2021) – InterVivo Solutions
Read moreQYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials New Global Industry Coalition That
Read moreNovavax Inc. has been incredibly explosive since May 2020. Since then, the stock has gapped from a low of $19
Read moreThe coronavirus is still wreaking havoc around the world. To date, total confirmed global cases are up to 3.6 million,
Read more